These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 31668409)

  • 21. How treatment improvement in ADHD and cocaine dependence are related to one another: A secondary analysis.
    Levin FR; Choi CJ; Pavlicova M; Mariani JJ; Mahony A; Brooks DJ; Nunes EV; Grabowski J
    Drug Alcohol Depend; 2018 Jul; 188():135-140. PubMed ID: 29775957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory toxicities from stimulant use.
    Albertson TE; Walby WF
    Clin Rev Allergy Immunol; 1997; 15(3):221-41. PubMed ID: 9358986
    [No Abstract]   [Full Text] [Related]  

  • 23. Understanding Stimulant Use and Use Disorders in a New Era.
    Ciccarone D; Shoptaw S
    Med Clin North Am; 2022 Jan; 106(1):81-97. PubMed ID: 34823736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant use in suicides: A systematic review.
    Mantinieks D; Schumann J; Drummer OH; Woodford NW; Gerostamoulos D
    Forensic Sci Int; 2022 Sep; 338():111391. PubMed ID: 35908335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Walking the line: stimulant use during sex and HIV risk behavior among Black urban MSM.
    Mimiaga MJ; Reisner SL; Fontaine YM; Bland SE; Driscoll MA; Isenberg D; Cranston K; Skeer MR; Mayer KH
    Drug Alcohol Depend; 2010 Jul; 110(1-2):30-7. PubMed ID: 20334986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-sectional cause of death comparisons for stimulant and opioid mortality in San Francisco, 2005-2015.
    Turner C; Chandrakumar D; Rowe C; Santos GM; Riley ED; Coffin PO
    Drug Alcohol Depend; 2018 Apr; 185():305-312. PubMed ID: 29486419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addictiveness of central stimulants.
    Dackis CA; Gold MS
    Adv Alcohol Subst Abuse; 1990; 9(1-2):9-26. PubMed ID: 1974121
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans.
    Ersche KD; Roiser JP; Robbins TW; Sahakian BJ
    Psychopharmacology (Berl); 2008 Apr; 197(3):421-31. PubMed ID: 18214445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
    Comer SD; Mogali S; Saccone PA; Askalsky P; Martinez D; Walker EA; Jones JD; Vosburg SK; Cooper ZD; Roux P; Sullivan MA; Manubay JM; Rubin E; Pines A; Berkower EL; Haney M; Foltin RW
    Neuropsychopharmacology; 2013 Nov; 38(12):2427-38. PubMed ID: 23736314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder.
    Leventhal AM; Kahler CW; Ray LA; Stone K; Young D; Chelminski I; Zimmerman M
    Am J Addict; 2008; 17(3):218-23. PubMed ID: 18463999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Stimulant Use With Dopaminergic Alterations in Users of Cocaine, Amphetamine, or Methamphetamine: A Systematic Review and Meta-analysis.
    Ashok AH; Mizuno Y; Volkow ND; Howes OD
    JAMA Psychiatry; 2017 May; 74(5):511-519. PubMed ID: 28297025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants?
    Mackey S; Paulus M
    Neurosci Biobehav Rev; 2013 Mar; 37(3):300-16. PubMed ID: 23253945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of dopamine in the mouse frontal cortex: a new hypothesis of behavioral sensitization to amphetamine and cocaine.
    Karler R; Calder LD; Thai DK; Bedingfield JB
    Pharmacol Biochem Behav; 1998 Dec; 61(4):435-43. PubMed ID: 9802839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An tale of two epidemics: HIV and stimulant use.
    Gorman M
    Focus; 1998 Mar; 13(4):1-3. PubMed ID: 11365170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective.
    Wood DM; Dargan PI
    Br J Clin Pharmacol; 2010 May; 69(5):443-7. PubMed ID: 20573079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blue-yellow colour vision impairment and cognitive deficits in occasional and dependent stimulant users.
    Hulka LM; Wagner M; Preller KH; Jenni D; Quednow BB
    Int J Neuropsychopharmacol; 2013 Apr; 16(3):535-47. PubMed ID: 22704223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and consequences of cocaine addiction.
    Karila L; Petit A; Lowenstein W; Reynaud M
    Curr Med Chem; 2012; 19(33):5612-8. PubMed ID: 22856661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulant dependence and stimulant-associated psychosis: clinical characteristics and age of onset in a native American community sample.
    Gilder DA; Gizer IR; Lau P; Ehlers CL
    J Addict Med; 2014; 8(4):241-8. PubMed ID: 24755633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the role of noradrenaline in psychostimulant-induced psychomotor activity and sensitization.
    Vanderschuren LJ; Beemster P; Schoffelmeer AN
    Psychopharmacology (Berl); 2003 Sep; 169(2):176-85. PubMed ID: 12768274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulant-induced hyperthermia and ice-water submersion: Practical considerations.
    Richards JR; Colby DK
    Clin Toxicol (Phila); 2016; 54(1):69-70. PubMed ID: 26515112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.